GB1320056A - Intigens and antibodies - Google Patents

Intigens and antibodies

Info

Publication number
GB1320056A
GB1320056A GB1462971*[A GB1462971A GB1320056A GB 1320056 A GB1320056 A GB 1320056A GB 1462971 A GB1462971 A GB 1462971A GB 1320056 A GB1320056 A GB 1320056A
Authority
GB
United Kingdom
Prior art keywords
opium alkaloid
derivative
opium
alkaloid
carrier material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1462971*[A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1320056A publication Critical patent/GB1320056A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB1462971*[A 1970-05-13 1971-05-13 Intigens and antibodies Expired GB1320056A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3699970A 1970-05-13 1970-05-13

Publications (1)

Publication Number Publication Date
GB1320056A true GB1320056A (en) 1973-06-13

Family

ID=21891894

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1462971*[A Expired GB1320056A (en) 1970-05-13 1971-05-13 Intigens and antibodies

Country Status (5)

Country Link
CA (1) CA966778A (enExample)
DE (1) DE2166716C3 (enExample)
DK (1) DK142145B (enExample)
GB (1) GB1320056A (enExample)
SE (4) SE389739B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
CN113968853B (zh) * 2020-07-22 2022-09-16 中国农业大学 阿托品类生物碱的半抗原、人工抗原及其制备方法与应用

Also Published As

Publication number Publication date
SE7408140L (enExample) 1974-06-19
DE2123300A1 (de) 1971-11-25
DE2166716A1 (de) 1975-04-24
CA966778A (en) 1975-04-29
DE2123300B2 (de) 1976-03-04
SE389739B (sv) 1976-11-15
DE2166716C3 (de) 1980-06-12
SE7408141L (enExample) 1974-06-19
DE2166716B2 (de) 1979-09-27
SE389737B (sv) 1976-11-15
DK142145C (enExample) 1981-02-02
SE417970B (sv) 1981-04-27
DK142145B (da) 1980-09-08

Similar Documents

Publication Publication Date Title
US3822245A (en) Opium alkaloid specific antibodies
US4550019A (en) Manufacture and use of fowl egg antibodies
US4048298A (en) Solid phase double-antibody radioimmunoassay procedure
DE3224837A1 (de) Traegergebundenes immunosorptionsmittel
ATE16567T1 (de) Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung.
GB1322000A (en) Preparation of antiserum specific for a carcinoembryonic antigen
GB1460522A (en) Process for the manufacture of antige-coated or antigen-coated or antigen-protein conjugate-coated erythrocytes
GB1409176A (en) Protein composition for labelling with technetium-99m and method of preparation
DE3850931T2 (de) Heterobifunktionelle Kupplungsmittel.
CN108264553B (zh) 一种重金属铅人工抗原的制备方法及nota在制备重金属铅人工抗原试剂中的应用
SE7408140L (enExample)
CN107955069B (zh) 一种改进的重金属铅人工抗原的合成方法及dota在制备重金属铅人工抗原试剂中的用途
Wal et al. Radioimmunoassay of penicilloyl groups in biological fluids
US5318913A (en) Reagent for the determination by hemagglutination of antibodies to bacterial toxins, method of preparation and application thereof
IL93234A (en) Methods for producing antibodies, antibody probes produced thereby, method for preparing and using antigens utilizing said probes and vaccines prepared therewith
EP0325723A3 (en) Method for the determination of blood clotting factors and reagent for use therein
CN102363634A (zh) 拟除虫菊酯类农药多克隆抗体的制备方法
Garvey et al. The in vivo stability of antibody
Jacobs et al. Complement-Fixation Tests on Rabbits with Brown-Pearce Carcinoma.
IE851279L (en) Conjugates of monovalent carboxylic ionophores
Richter et al. Fluoro-immuno-cytoadherence (FICA): A new method for the identification and enumeration of antigen-binding cells
JPS57109724A (en) Novel hapten antigen and its preparation
DE69610283T2 (de) Verfahren zur immunologischen Identifizierung oder Bestimmung von Polypeptid-Antigenen
RU2240823C2 (ru) Способ получения флуоресцирующего антивидового конъюгата против ig g человека или животного для реакции непрямой иммунофлуоресценции
US3770584A (en) Pronase purification

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee